FDA Warning Letter — U.S. Continental Marketing, Inc.
The FDA took a Warning Letter action against U.S. Continental Marketing, Inc. on May 2, 2019 (Corona, CA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- U.S. Continental Marketing, Inc.
- Date
- May 2, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Corona, CA (United States)